Federal contractor · ATHENS, GA

LECTENZ BIO, INC.

No contract obligations recorded for LECTENZ BIO, INC. in FY2026. It also received $1M in federal grants and other assistance in FY2026.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
JTGCK219C6F4
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 0FY2017

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for LECTENZ BIO, INC. in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

LECTENZ BIO, INC. received $1M in federal assistance in FY2026, on 3 actions (0 new awards), −20% vs FY2025. Its largest program was 93.859 · Biomedical Research and Research Training ($1M).

Assistance · FY2026
$1M
New awards
0
Actions
3
Since FY2021
$6.9M

Assistance by fiscal year

  1. 1.2MFY2021
  2. 37.2KFY2022
  3. 1.3MFY2023
  4. 2MFY2024
  5. 1.3MFY2025
  6. 1MFY2026

By type

  1. Grants$1M100%

Top programs

  1. 93.859 · Biomedical Research and Research Training$1M100%

Awarding agencies

  1. National Institutes of Health$1M100%
    Department of Health and Human Services

Largest awards

  1. ENGINEERED PAN-SPECIFIC REAGENTS FOR N-GLYCAN DETECTION AND ENRICHMENT - PROJECT SUMMARY GLYCANS PLAY CRUCIAL ROLES IN NEARLY EVERY ASPECT…$2.3M
    93.351 · Research Infrastructure Programs· National Institutes of Health· Project grant· Jul 20, 2023 – Jun 3, 2026· R44OD035390
  2. A NEW APPROACH TO MONITORING GLYCOSYLATION DURING GLYCOPROTEIN PRODUCTION - PROJECT SUMMARY DURING THE PRODUCTION OF THERAPEUTIC…$2M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Sep 15, 2023 – Sep 9, 2026· R44GM153145
  3. INNOVATIVE GLYCAN-SPECIFIC REAGENTS TO ACCELERATE THE DETECTION OF DISEASE BIOMARKERS - PROJECT SUMMARY GLYCANS HAVE SEVERAL DISTINCT…$1.4M
    93.859 · Biomedical Research and Research Training· National Institutes of Health· Project grant· Jul 18, 2025 – Aug 24, 2026· R44GM159548

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2021–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.